CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT06562270
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 17 Years
Healthy Volunteers
Not accepted

Study Details

Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.

Key Dates

Start date
Mar 7, 2024
Status verified
Jan 2026
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

AA epidemiology, presentation, natural history, management, and outcomes [ Time Frame: Through Study completion until the subject is 18 years ]

Central Contacts

  • CorEvitas

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451
Cathy Cheney
[email protected]
508-555-1212
[email protected]
508-555-1212

Find similar trials in Waltham, MA

By research site
CorEvitas, LLC· Waltham, MA

Related Studies